These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 34976741)

  • 1. The role of genetic modifiers, inflammation and CFTR in the pathogenesis of Cystic fibrosis related diabetes.
    Hasan S; Soltman S; Wood C; Blackman SM
    J Clin Transl Endocrinol; 2022 Mar; 27():100287. PubMed ID: 34976741
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Potential Causes of Cystic Fibrosis-Related Diabetes.
    Coderre L; Debieche L; Plourde J; Rabasa-Lhoret R; Lesage S
    Front Endocrinol (Lausanne); 2021; 12():702823. PubMed ID: 34394004
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic Modifiers of Cystic Fibrosis-Related Diabetes Have Extensive Overlap With Type 2 Diabetes and Related Traits.
    Aksit MA; Pace RG; Vecchio-Pagán B; Ling H; Rommens JM; Boelle PY; Guillot L; Raraigh KS; Pugh E; Zhang P; Strug LJ; Drumm ML; Knowles MR; Cutting GR; Corvol H; Blackman SM
    J Clin Endocrinol Metab; 2020 May; 105(5):1401-15. PubMed ID: 31697830
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Islet-intrinsic effects of CFTR mutation.
    Koivula FNM; McClenaghan NH; Harper AGS; Kelly C
    Diabetologia; 2016 Jul; 59(7):1350-1355. PubMed ID: 27033560
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Islet Function in the Pathogenesis of Cystic Fibrosis-Related Diabetes Mellitus.
    Westholm E; Wendt A; Eliasson L
    Clin Med Insights Endocrinol Diabetes; 2021; 14():11795514211031204. PubMed ID: 34345195
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cystic fibrosis-related diabetes is caused by islet loss and inflammation.
    Hart NJ; Aramandla R; Poffenberger G; Fayolle C; Thames AH; Bautista A; Spigelman AF; Babon JAB; DeNicola ME; Dadi PK; Bush WS; Balamurugan AN; Brissova M; Dai C; Prasad N; Bottino R; Jacobson DA; Drumm ML; Kent SC; MacDonald PE; Powers AC
    JCI Insight; 2018 Apr; 3(8):. PubMed ID: 29669939
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beyond insulin: Unraveling the complex interplay of ER stress, oxidative damage, and CFTR modulation in CFRD.
    Umashankar B; Eliasson L; Ooi CY; Kim KW; Shaw JAM; Waters SA
    J Cyst Fibros; 2024 Sep; 23(5):842-852. PubMed ID: 38897882
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heterogeneous expression of CFTR in insulin-secreting β-cells of the normal human islet.
    Di Fulvio M; Bogdani M; Velasco M; McMillen TS; Ridaura C; Kelly L; Almutairi MM; Kursan S; Sajib AA; Hiriart M; Aguilar-Bryan L
    PLoS One; 2020; 15(12):e0242749. PubMed ID: 33264332
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cystic Fibrosis-Related Diabetes (CFRD): Overview of Associated Genetic Factors.
    Iafusco F; Maione G; Rosanio FM; Mozzillo E; Franzese A; Tinto N
    Diagnostics (Basel); 2021 Mar; 11(3):. PubMed ID: 33810109
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CFTR silencing in pancreatic β-cells reveals a functional impact on glucose-stimulated insulin secretion and oxidative stress response.
    Ntimbane T; Mailhot G; Spahis S; Rabasa-Lhoret R; Kleme ML; Melloul D; Brochiero E; Berthiaume Y; Levy E
    Am J Physiol Endocrinol Metab; 2016 Feb; 310(3):E200-12. PubMed ID: 26625901
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evolving Mechanistic Views and Emerging Therapeutic Strategies for Cystic Fibrosis-Related Diabetes.
    Yoon JC
    J Endocr Soc; 2017 Nov; 1(11):1386-1400. PubMed ID: 29264462
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of modulators in cystic fibrosis related diabetes.
    Merjaneh L; Hasan S; Kasim N; Ode KL
    J Clin Transl Endocrinol; 2022 Mar; 27():100286. PubMed ID: 34917484
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic modifiers of cystic fibrosis-related diabetes.
    Blackman SM; Commander CW; Watson C; Arcara KM; Strug LJ; Stonebraker JR; Wright FA; Rommens JM; Sun L; Pace RG; Norris SA; Durie PR; Drumm ML; Knowles MR; Cutting GR
    Diabetes; 2013 Oct; 62(10):3627-35. PubMed ID: 23670970
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cystic Fibrosis-Related Diabetes Workshop: Research Priorities Spanning Disease Pathophysiology, Diagnosis, and Outcomes.
    Putman MS; Norris AW; Hull RL; Rickels MR; Sussel L; Blackman SM; Chan CL; Ode KL; Daley T; Stecenko AA; Moran A; Helmick MJ; Cray S; Alvarez JA; Stallings VA; Tuggle KL; Clancy JP; Eggerman TL; Engelhardt JF; Kelly A
    Diabetes Care; 2023 Jun; 46(6):1112-1123. PubMed ID: 37125948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pancreas and islet morphology in cystic fibrosis: clues to the etiology of cystic fibrosis-related diabetes.
    Malik SS; Padmanabhan D; Hull-Meichle RL
    Front Endocrinol (Lausanne); 2023; 14():1269139. PubMed ID: 38075070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Survival in a bad neighborhood: pancreatic islets in cystic fibrosis.
    Norris AW; Ode KL; Merjaneh L; Sanda S; Yi Y; Sun X; Engelhardt JF; Hull RL
    J Endocrinol; 2019 Feb; ():. PubMed ID: 30759072
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of endocrine disease: Cystic fibrosis-related diabetes: novel pathogenic insights opening new therapeutic avenues.
    Barrio R
    Eur J Endocrinol; 2015 Apr; 172(4):R131-41. PubMed ID: 25336504
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of cystic fibrosis transmembrane conductance regulator modulators on impaired glucose tolerance and cystic fibrosis related diabetes.
    Hasan S; Khan MS; Lansang MC
    J Clin Transl Endocrinol; 2022 Sep; 29():100301. PubMed ID: 35746945
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Islet Interleukin-1β Immunoreactivity Is an Early Feature of Cystic Fibrosis That May Contribute to β-Cell Failure.
    Hull RL; Gibson RL; McNamara S; Deutsch GH; Fligner CL; Frevert CW; Ramsey BW; Sanda S
    Diabetes Care; 2018 Apr; 41(4):823-830. PubMed ID: 29437698
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cystic Fibrosis-Related Diabetes: Pathophysiology and Therapeutic Challenges.
    Kelsey R; Manderson Koivula FN; McClenaghan NH; Kelly C
    Clin Med Insights Endocrinol Diabetes; 2019; 12():1179551419851770. PubMed ID: 31191067
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.